Advances in Human Norovirus Vaccine Research

Human norovirus (HuNoV) is the leading cause of acute gastroenteritis (AGE) worldwide, which is highly stable and contagious, with a few virus particles being sufficient to establish infection. Although the World Health Organization in 2016 stated that it should be an absolute priority to develop a...

Full description

Bibliographic Details
Main Authors: Mudan Zhang, Ming Fu, Qinxue Hu
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/7/732
_version_ 1797526016250347520
author Mudan Zhang
Ming Fu
Qinxue Hu
author_facet Mudan Zhang
Ming Fu
Qinxue Hu
author_sort Mudan Zhang
collection DOAJ
description Human norovirus (HuNoV) is the leading cause of acute gastroenteritis (AGE) worldwide, which is highly stable and contagious, with a few virus particles being sufficient to establish infection. Although the World Health Organization in 2016 stated that it should be an absolute priority to develop a HuNoV vaccine, unfortunately, there is currently no licensed HuNoV vaccine available. The major barrier to the development of an effective HuNoV vaccine is the lack of a robust and reproducible in vitro cultivation system. To develop a HuNoV vaccine, HuNoV immunogen alone or in combination with other viral immunogens have been designed to assess whether they can simultaneously induce protective immune responses against different viruses. Additionally, monovalent and multivalent vaccines from different HuNoV genotypes, including GI and GII HuNoV virus-like particles (VLPs), have been assessed in order to induce broad protection. Although there are several HuNoV vaccine candidates based on VLPs that are being tested in clinical trials, the challenges to develop effective HuNoV vaccines remain largely unresolved. In this review, we summarize the advances of the HuNoV cultivation system and HuNoV vaccine research and discuss current challenges and future perspectives in HuNoV vaccine development.
first_indexed 2024-03-10T09:21:14Z
format Article
id doaj.art-ec0d59800ac04451a1e21224d4eaf209
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T09:21:14Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-ec0d59800ac04451a1e21224d4eaf2092023-11-22T05:12:11ZengMDPI AGVaccines2076-393X2021-07-019773210.3390/vaccines9070732Advances in Human Norovirus Vaccine ResearchMudan Zhang0Ming Fu1Qinxue Hu2Department of Gastroenterology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou 510623, ChinaThe Joint Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou 510623, ChinaState Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, ChinaHuman norovirus (HuNoV) is the leading cause of acute gastroenteritis (AGE) worldwide, which is highly stable and contagious, with a few virus particles being sufficient to establish infection. Although the World Health Organization in 2016 stated that it should be an absolute priority to develop a HuNoV vaccine, unfortunately, there is currently no licensed HuNoV vaccine available. The major barrier to the development of an effective HuNoV vaccine is the lack of a robust and reproducible in vitro cultivation system. To develop a HuNoV vaccine, HuNoV immunogen alone or in combination with other viral immunogens have been designed to assess whether they can simultaneously induce protective immune responses against different viruses. Additionally, monovalent and multivalent vaccines from different HuNoV genotypes, including GI and GII HuNoV virus-like particles (VLPs), have been assessed in order to induce broad protection. Although there are several HuNoV vaccine candidates based on VLPs that are being tested in clinical trials, the challenges to develop effective HuNoV vaccines remain largely unresolved. In this review, we summarize the advances of the HuNoV cultivation system and HuNoV vaccine research and discuss current challenges and future perspectives in HuNoV vaccine development.https://www.mdpi.com/2076-393X/9/7/732human norovirusacute gastroenteritisHuNoV vaccineVLPsculture system
spellingShingle Mudan Zhang
Ming Fu
Qinxue Hu
Advances in Human Norovirus Vaccine Research
Vaccines
human norovirus
acute gastroenteritis
HuNoV vaccine
VLPs
culture system
title Advances in Human Norovirus Vaccine Research
title_full Advances in Human Norovirus Vaccine Research
title_fullStr Advances in Human Norovirus Vaccine Research
title_full_unstemmed Advances in Human Norovirus Vaccine Research
title_short Advances in Human Norovirus Vaccine Research
title_sort advances in human norovirus vaccine research
topic human norovirus
acute gastroenteritis
HuNoV vaccine
VLPs
culture system
url https://www.mdpi.com/2076-393X/9/7/732
work_keys_str_mv AT mudanzhang advancesinhumannorovirusvaccineresearch
AT mingfu advancesinhumannorovirusvaccineresearch
AT qinxuehu advancesinhumannorovirusvaccineresearch